Decurarisation Kinetics of Rocuronium in Cervical Surgery
CIDEROC
Evaluation of the Decurarisation Kinetics of Rocuronium in Cervical Surgery
1 other identifier
observational
50
1 country
1
Brief Summary
Recurrent nerve monitoring for thyroid and parathyroid surgery contraindicates the pharmacologically active presence of muscle relaxant agents at the time of dissection. A recent formalized expert guideline (RFE 2018) from the French Society of Anesthesia and Resuscitation, SFAR recommends administering a curare to facilitate tracheal intubation and limit laryngeal trauma . This study aims to determine if the level of neuromuscular recovery is consistent with monitoring the recurrent nerve after the use of rocuronium for intubation. Primary endpoint: Achievement of quality intraoperative laryngeal recurrent nerve monitoring.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 8, 2021
CompletedFirst Posted
Study publicly available on registry
November 18, 2021
CompletedStudy Start
First participant enrolled
January 6, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
May 30, 2022
CompletedSeptember 12, 2025
September 1, 2025
5 months
November 8, 2021
September 5, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Quality intraoperative monitoring of the recurrent laryngeal nerve
To assess the decurarization kinetics of rocuronium: to determine if the level of neuromuscular recovery is compatible with monitoring of the recurrent nerve after the use of rocuronium for intubation
During surgery
Secondary Outcomes (3)
Copenhagen score
During surgery
Arterial pressions
During surgery
Cardiac frequency
During surgery
Interventions
Thyroid and parathyroid surgery
Recurrent nerves monitoring
Eligibility Criteria
Major, non-morbidly obese patients (BMI\<35) requiring general anesthesia with intubation with a Nerve Integrity Monitor (NIM) tube for thyroid and parathyroid surgery.
You may qualify if:
- Adult subjects requiring general anesthesia for cephalic surgery (thyroid and parathyroid) with an NIM-type intubation tube.
- Subject informed of the study and not having opposed it
You may not qualify if:
- Allergy to any of the products used
- Morbidly obese subjects (BMI\> 35)
- Pregnancy
- Predictive criteria for difficult intubation in pre-anesthetic consultation
- Subjects under tutorship or curatorship
- Subjects not affiliated to social security
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Surgical anesthesia service - Cochin Hospital
Paris, IDF, 75014, France
Related Publications (1)
Marquet Y, Philippe A, Toussaint S, Abdallah SB, Morel-Fatio E, Baillard C. Rocuronium with sugammadex as a rescue reversal agent to solve conflicting recommendations for thyroid or parathyroid surgery. A prospective study. Anaesth Crit Care Pain Med. 2023 Aug;42(4):101214. doi: 10.1016/j.accpm.2023.101214. Epub 2023 Mar 6.
PMID: 36889437BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 8, 2021
First Posted
November 18, 2021
Study Start
January 6, 2022
Primary Completion
May 30, 2022
Study Completion
May 30, 2022
Last Updated
September 12, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share